Abstract
Oridonin, a natural diterpenoid purified from Rabdosia rubescens, has displayed beneficial biological activities, including anti-proliferation and anti-angiogenesis effects, in various types of cancers. However, the anti-cancer potential of oridonin and its mechanism in oral cancer have never previously been studied. In this study, we assessed the role of oridonin as an inducer of apoptosis in HSC-3 and HSC-4 human oral cancer cells. Our results showed that oridonin reduces the viability of human oral cancer cells and significantly increases the expression of γH2AX, a well-known marker of DNA damage. 4',6-Diamidino-2-phenylindole (DAPI) staining and western blotting showed that oridonin causes nuclear condensation and fragmentation, and induces cleavage of poly(ADP-ribose) polymerase (PARP). Moreover, oridonin-induced γH2AX accumulation was partially abrogated by Z-VAD, a pan-caspase inhibitor. Taken together, our results suggest that oridonin can effectively induce apoptosis by augmenting the expression of γH2AX in response to DNA damage and might be a promising anti-cancer drug candidate for the treatment of oral cancer.
References
Mar 15, 2002·Current Opinion in Genetics & Development·Christophe RedonWilliam Bonner
Oct 7, 2004·Biological & Pharmaceutical Bulletin·Chun-Ling ZhangTakashi Ikejima
Jul 16, 2005·Leukemia & Lymphoma·Jiajun LiuFeng Chen
Sep 24, 2005·Biochemical and Biophysical Research Communications·Tze-Chen HsiehJoseph M Wu
Jul 5, 2006·Molecular Cell·Chengrong LuZigang Dong
Jan 16, 2007·Cancer Biology & Therapy·Song JinJia-Guo Zhou
Oct 26, 2007·Acta Pharmacologica Sinica·Hong-zhen HuHai-tao Zeng
Dec 18, 2007·Molecular Cell·J Wade Harper, Stephen J Elledge
Feb 21, 2008·Journal of Radiation Research·Junya KobayashiHiroshi Tauchi
Sep 23, 2008·Mutation Research·Niloo SrivastavaRameshwar N K Bamezai
Feb 5, 2010·Leukemia·L-J MahT C Karagiannis
Oct 31, 2012·Cell Proliferation·Z LiuW-Z Zhang
Jan 23, 2013·The American Journal of Chinese Medicine·Shengpeng WangYitao Wang
Jun 22, 2013·Contemporary Oncology Współczesna Onkologia·Tao ZhangZhaoyang Liu
Dec 4, 2013·Oncology Reports·He-Qi BuJun-Hui Cui
Mar 25, 2014·BMC Cancer·Runfa BaoYingbin Liu
Jul 23, 2014·Molecular Medicine Reports·Yu ZhuBin Hao
Aug 16, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Shi-Yong GaoYu-Bin Ji
Feb 6, 2015·Acta Biochimica Et Biophysica Sinica·Bin XuJian Xu
May 29, 2015·Journal of Natural Medicines·Guowen RenXiuping Chen
Sep 29, 2015·Leukemia & Lymphoma·Zi-Zhen XuJun-Min Li
Nov 23, 2015·DNA Repair·Raafat A El-AwadyTaleb H Al-Tel
Mar 2, 2016·Asian Pacific Journal of Cancer Prevention : APJCP·Rong XiaAn-Mei Deng
Jul 9, 2016·Cancer Letters·Jing WuCeshi Chen
Aug 25, 2016·Journal of Hematology & Oncology·Kai QingJunmin Li
Apr 6, 2017·BMC Complementary and Alternative Medicine·Lili TianGuofu Zhu
Apr 21, 2017·Oncotarget·Jun YangZhu Yuan
Apr 26, 2017·Journal of Pineal Research·Maryam MajidiniaBahman Yousefi
Citations
Apr 28, 2018·Cell and Tissue Banking·Sara Alicia González PortoEsther Rendal Vázquez
May 6, 2019·Oral Diseases·Huamei YangQianming Chen
May 30, 2020·International Journal of Oncology·Jung-Min HanSeong-Doo Hong
Apr 3, 2019·Journal of Clinical Biochemistry and Nutrition·Dong-Hoon WonSung-Dae Cho
Oct 19, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Su-Jung ChoiSung-Dae Cho
Nov 14, 2019·Chinese Medicine·Hua LuoYitao Wang
Nov 30, 2019·Journal of Clinical Biochemistry and Nutrition·Hye-Jeong KwonSung-Dae Cho
Jun 30, 2019·ACS Applied Materials & Interfaces·Dongdong ChaiHong Jiang
Dec 9, 2021·Epigenomics·Xiaofeng DaiDong Hua
Oct 24, 2020·European Journal of Pharmacology·Seyed Ali MosaddadHamid Tebyanian